Comcast is in acquisition mode and rapidly embracing advanced technologies. But as it seeks new avenues for growth, will this multi-media colossus get stretched too thin? Read More
John Persinos is managing editor of Personal Finance, Utility Forecaster, and Radical Wealth Alliance. He also writes the Mind Over Markets daily stock market recap.
John has decades of experience in the technology and political realms. He's spent decades following emerging business and technology developments. From his time at Inc. and Venture magazines, to sharing breaking market news to millions of readers across Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, if it's impacted investors in the past 30 years, John was there analyzing the news and interpreting the meaning for his readers. John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Merck has been a money-making machine for decades, but it faces growing competition and patent expirations. Will this drug giant prevail? Read More
Home Depot is a DJIA component and steady dividend payer. But do economic headwinds and a cooling housing sector pose threats to this retail icon and its payout? Read More
Pfizer is a growth-and-income stock found in many retirement portfolios. But is the competition from biotech "disruptors" getting too hot for this Big Pharma stalwart? Read More
In this week's "Big Interview," Investing Daily analyst Jim Fink reveals his proprietary method for pinpointing buy signals and crushing the market. Read More
Chevron is poised to gain from rising crude prices, but the energy sector remains volatile. Can this "super major" overcome the industry's uncertainties? Read More
As the largest health insurer in the U.S., UnitedHealth Group is poised to greatly benefit from booming health care expenditures. But do proposed government policy changes threaten the stock? Read More
Health services giant Johnson & Johnson has been a reliable growth-and-income stock for years, but can it overcome the scandal about its allegedly carcinogenic talcum powder? Read More
General Motors has proven itself a survivor, emerging from the federal government bailout in competitive shape. But disruptive technology and economic storm clouds now threaten this Detroit icon. Read More
Cash-rich tech titans such as Microsoft have become growth-and-income plays. But as headwinds mount for the tech sector, how safe is the firm's dividend? Read More